Collectively, this study demonstrates that phlorotannins suppress ovarian cancer cell migration and invasion by up to approximately 60% and attenuate pro-metastatic MMP expression and activity through coordinated modulation of IL-17RA/Act1 signaling and early ERK1/2 activation. Here, MAPK3 is linked to ovarian carcinoma.